Short interest in Tourmaline Bio Inc (NASDAQ:TRML) increased during the last reporting period, rising from 2.71M to 3.13M. This put 13.67% of the company's publicly available shares short.

TOURMALINE BIO ($TRML) posted quarterly earnings results on Thursday, March 13th. The company reported earnings of -$0.86 per share, beating estimates of -$0.89 by $0 ...

NASDAQ:TRML opened at $17.33 on Friday. Tourmaline Bio has a 52-week low of $11.87 and a 52-week high of $45.55. The stock has a fifty day simple moving average of $15.58 and a 200-day simple ...

Tourmaline Bio (NASDAQ:TRML – Get Free Report) had its price objective lifted by analysts at HC Wainwright from $49.00 to $50.00 in a research report issued on Friday,Benzinga reports.